Japanese company profile · 4934

プレミアアンチエイジング株式会社

The original Japanese company name is shown; no English name has been verified.

FY2025 · fiscal year ended July 2026Latest filing date: 2026-10-23

What does this company do?

What does this company do?

The latest available public filing reports Anti-aging business, Recovery business. The original Japanese company name is shown with the source information.

This company's largest reported business by revenue in FY2025 was Anti-aging business.

The business with the highest reported segment profit in FY2025 was Anti-aging business.

FY2025 · fiscal year ended July 2026 · View original filing ↗ The source document may be in Japanese.

Reported company-wide figures

Company revenue
¥13.88B ↗
FY2025 · fiscal year ended July 2026
Operating profit
¥494M ↗
FY2025 · fiscal year ended July 2026
Comparable margin
3.6% ↗
FY2025 · fiscal year ended July 2026

JGAAP · Consolidated company-wide

Company profile

Company profile

Identity

Securities code
4934
EDINET code
E36046
Corporate number
2010401085273
Listing status
Listed
Industry (EDINET filer classification)
Chemicals

Location and fiscal year

Headquarters
東京都港区 · As filed in Japanese
Fiscal year end
7month
Latest fiscal year
FY2025
Accounting standard
JGAAP
P16 data snapshot
2026-11-07

Company size

Employees (consolidated)
228 people (FY2025)
Employees (non-consolidated)
170 people (FY2025)
Capital stock
JPY 50.0 million (FY2025)

Official information

Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab

Business structure

How does it make money?

Revenue leader and profit leader

Anti-aging business

FY2025 · fiscal year ended July 2026 · Business Sales Operating profit
BusinessSalesShare of company salesOperating profitMargin
Anti-aging business¥10.35B ↗74.5%74.5%Sales to external customers: ¥10.35B ↗¥660M ↗6.4%
Recovery business¥3.53B ↗25.4%25.4%Sales to external customers: ¥3.53B ↗−¥165M ↗-4.7%

All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended July 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.

Company revenue

Company-wide trend

Company revenue

JGAAP · Consolidated
  1. FY202096.8¥32.82B
  2. FY2021100.0¥33.91B
  3. FY202360.0¥20.36B
  4. FY202447.7¥16.16B
  5. FY202540.9¥13.88B

Company operating profit

JGAAP · Consolidated
  1. FY2020100.0¥4.68B
  2. FY202151.6¥2.41B
  3. FY20233.0¥139M
  4. FY202413.2¥617M
  5. FY202510.6¥494M

Only reported years are shown. Missing years are left blank; accounting standards and scopes are kept in separate series.

What has changed?

Businesses reported in earlier filings

Reporting labels alone do not prove that a business started, ended, merged, or changed its identity.

  • 化粧品の製造・販売事業 (Original Japanese label)FY 2020–FY 2021 · Source

What is growing?

What is growing?

No comparable reported revenue growth is available.

What has changed?

What has changed?

A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.

Source

Company profile

These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.

  • Growth3
    Peer-position scoreFY2025
  • Profitability16
    Peer-position scoreFY2025
  • Business concentration56
    Peer-position scoreFY2025
  • Business change89
    Peer-position scoreFY2023→FY2025
  • Cash generation4
    Peer-position scoreFY2025
  • Growth persistence8
    Peer-position scoreFY2020→FY2021, FY2023→FY2024, FY2024→FY2025

Next

Ask about this company

Source

Public filing

FY2025 · fiscal year ended July 2026

The source document may be in Japanese.

Filing ID: S100Z9QW

View original filing ↗
Original Japanese label
Original Japanese label
化粧品の製造・販売事業

根拠となる資料